abstract |
A compound that modulates or inhibits the enzymatic activity of an indoleamine 2,3-dioxygenase (IDO), a pharmaceutical composition containing such a compound, and a compound of the present invention may be used to treat a proliferative disorder such as cancer, Or inflammatory disorders are disclosed. |